Allurion Technologies(us:ALUR)

3.31

+3.12%

Updated on 2025-04-02

Open:3.22
Close:3.31
High:3.35
Low:3.08
Prev Close:3.21
Volume:134837.00
Turnover:438971.66
Turnover Ratio:2.26%
Shares:5.96M
MarketCap:19.74M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30401045338621.79%13911
2024-03-3133755946115.78%6610
2023-12-3129759427215.93%693
2023-09-3085622440113.11%16267
2023-06-30741350130943.90%21126
2023-03-3135474799415.44%1063
2022-12-3112233586263.12%104104
2022-09-301286806252363.13%173730
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Rtw Investments, Lp34577077.22%0
2024-03-31Fortress Investment Group Llc12840042.68%0
2024-03-31Unisphere Establishment12423302.59%0
2024-03-31Blackrock Inc.4713900.98%-18141-3.71%
2024-03-31Vanguard Group Inc4685630.98%30480.66%
2024-03-31Geode Capital Management, Llc3449090.72%213056.58%
2024-03-31Northern Trust Corp696190.15%0
2024-03-31State Street Corp439140.09%-13000-22.84%
2024-03-31Sage Rock Capital Management Lp420000.09%0
2024-03-31Accredited Investors Inc.375000.08%0

About

Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.
Address:11 Huron Drive

Market Movers